DOE Patents title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: 12-gene prognostic signature for breast cancer survival

Abstract

A biomarker panel of 12 genes based on expression levels. Methods for calculating prognostic scores and patient ranking based on their score and divided into two equal sized cohorts. Kaplan-Meier analysis and a log-rank test were used to determine differences in survival.

Inventors:
; ;
Issue Date:
Research Org.:
Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA (United States)
Sponsoring Org.:
USDOE
OSTI Identifier:
1771765
Patent Number(s):
10876167
Application Number:
15/870,693
Assignee:
The Regents of the University of California (Oakland, CA)
Patent Classifications (CPCs):
C - CHEMISTRY C12 - BIOCHEMISTRY C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS
G - PHYSICS G16 - INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS G16B - BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
DOE Contract Number:  
AC02-05CH11231
Resource Type:
Patent
Resource Relation:
Patent File Date: 01/12/2018
Country of Publication:
United States
Language:
English

Citation Formats

Snijders, Antoine M., Mao, Xuan Yu, and Lee, Matthew J. 12-gene prognostic signature for breast cancer survival. United States: N. p., 2020. Web.
Snijders, Antoine M., Mao, Xuan Yu, & Lee, Matthew J. 12-gene prognostic signature for breast cancer survival. United States.
Snijders, Antoine M., Mao, Xuan Yu, and Lee, Matthew J. Tue . "12-gene prognostic signature for breast cancer survival". United States. https://www.osti.gov/servlets/purl/1771765.
@article{osti_1771765,
title = {12-gene prognostic signature for breast cancer survival},
author = {Snijders, Antoine M. and Mao, Xuan Yu and Lee, Matthew J.},
abstractNote = {A biomarker panel of 12 genes based on expression levels. Methods for calculating prognostic scores and patient ranking based on their score and divided into two equal sized cohorts. Kaplan-Meier analysis and a log-rank test were used to determine differences in survival.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {2020},
month = {12}
}

Works referenced in this record:

An Iron Regulatory Gene Signature Predicts Outcome in Breast Cancer
journal, August 2011


Multiple Pathways of TWEAK-Induced Cell Death
journal, January 2002


Cancer statistics, 2014: Cancer Statistics, 2014
journal, January 2014


Tissue-Wide Expression Profiling Using cDNA Subtraction and Microarrays to Identify Tumor-Specific Genes
journal, February 2004


Breast Cancer Incidence, 1980 2006: Combined Roles of Menopausal Hormone Therapy, Screening Mammography, and Estrogen Receptor Status
journal, July 2007


Breast cancer statistics, 2013: Breast Cancer Statistics, 2013
journal, October 2013


Identification of early molecular markers for breast cancer
journal, January 2011


Polymorphic variants in TSC1 and TSC2 and their association with breast cancer phenotypes
journal, July 2010


Progress in adjuvant chemotherapy for breast cancer: an overview
journal, August 2015


X chromosomal abnormalities in basal-like human breast cancer
journal, February 2006


The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
journal, April 2012


WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): update 2013
journal, May 2013


Proliferative genes dominate malignancy-risk gene signature in histologically-normal breast tissue
journal, March 2009


WebGestalt: an integrated system for exploring gene sets in various biological contexts
journal, July 2005


TSC1-2 tumour suppressor and regulation of mTOR signalling: linking cell growth and proliferation?
journal, February 2005


Subtle variations in Pten dose determine cancer susceptibility
journal, April 2010


An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
journal, December 2009


The maternal embryonic leucine zipper kinase (MELK) is upregulated in high-grade prostate cancer
journal, September 2012


Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
journal, March 2009


Ahnak functions as a tumor suppressor via modulation of TGFβ/Smad signaling pathway
journal, March 2014


Maternal embryonic leucine zipper kinase is a key regulator of the proliferation of malignant brain tumors, including brain tumor stem cells
journal, January 2008


A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
journal, December 2004


Complexities in the estimation of overdiagnosis in breast cancer screening
journal, September 2008


Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer
journal, February 2005


High TIMM17A expression is associated with adverse pathological and clinical outcomes in human breast cancer
journal, October 2010


Adjuvant therapy for breast cancer: who should get what?
journal, April 2001


Lipid phosphate phosphatase-1 expression in cancer cells attenuates tumor growth and metastasis in mice
journal, November 2014


USP47 Is a Deubiquitylating Enzyme that Regulates Base Excision Repair by Controlling Steady-State Levels of DNA Polymerase β
journal, March 2011


The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes
journal, May 2016


An AMPK-Independent Signaling Pathway Downstream of the LKB1 Tumor Suppressor Controls Snail1 and Metastatic Potential
journal, August 2014


TSC2 modulates actin cytoskeleton and focal adhesion through TSC1-binding domain and the Rac1 GTPase
journal, December 2004


Heterogeneous nuclear ribonucleoprotein K upregulates the kinetochore complex component NUF2 and promotes the tumorigenicity of colon cancer cells
journal, March 2015


Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
journal, March 2013


Increased Expression of the Tumor Suppressor PLZF Is a Continuous Predictor of Long-Term Survival in Malignant Melanoma Patients
journal, August 2008


The human transcriptome across tissues and individuals
journal, May 2015


Down-regulation of tensin2 enhances tumorigenicity and is associated with a variety of cancers
journal, May 2016


Prognostic and Predictive Factors in Early‐Stage Breast Cancer
journal, November 2004


The calcium-binding protein S100P in normal and malignant human tissues
journal, February 2008


Dysregulated expression of Fau and MELK is associated with poor prognosis in breast cancer
journal, August 2009


The ubiquitin-specific protease USP47 is a novel β-TRCP interactor regulating cell survival
journal, December 2009


Gene expression profiling predicts clinical outcome of breast cancer
journal, January 2002


CREBRF is a potent tumor suppressor of glioblastoma by blocking hypoxia-induced autophagy via the CREB3/ATG5 pathway
journal, June 2016